Similarly,
Tabapsy: study experiences tobacco reduction:
A vast study experiences a tobacco reduction intervention specially dedicated to users of ambulatory psychiatry. Moreover, according to their needs. Similarly, Objectives: to help reduce the smoking rate of this population, public health issue. However, Step.
Social health inequalities related to tobacco in people faced with mental disorders are known. Furthermore, Indeed. Similarly, the high prevalence of smoking in this population partly explains their reduced life expectancy, from 10 to 25 years depending on the disorders (1) by comparison to the general population, due to the occurrence of cardiovascular and respiratory pathologies (2). However. Nevertheless, few aids and advice on tobacco consumption are intended for them (3), including in psychiatry where the supply of treatments in tobaccoology is unevenly developed and tobacco often invested in the hospital as a modality of relational management (4).
In this context. Moreover, Tabapsy research consists in tabapsy: study experiences tobacco reduction developing a tobacco reduction intervention for users followed in ambulatory psychiatry, then experimenting and evaluating it. Therefore, This project is carried out by the Grouping of Health Cooperation. Similarly, the Collaborator Center of the World Health Organization (GCS-COMS) for mental research and training, and by the Evaluation and Research Team in health services and policies for vulnerable populations (ECEVE, UMR 1123) of INSERM.
To achieve the target objectives. In addition, research is based on a mixed method, combining tools (questionnaires, interviews), qualitative and quantitative approaches and different disciplines (public health, health economics, sociology), associated with a participative and collaborative approach with the various stakeholders.
In a first phase, the tobacco reduction intervention was developed, starting from the needs expressed by users. It takes into account acceptability in psychiatry. the expectations of general practitioners, and incorporates the lessons of a review of the literature and a qualitative study on the reality tabapsy: study experiences tobacco reduction of smoking from the point of view of the persons concerned and the caregivers of psychiatry (5). At this stage of research, it remains confidential and reserved for medico-psychological centers which participate in its experiment.
Ten people (ex-) smokers concerned by mental disorders have been recruited to test the tools for promoting intervention. study, and/or to testify to their tobacco experiences in the context of video interviews intended to raise awareness of mental health users about the decrease or stopping smoking. Professionals in addictology-tabacology and/or psychiatry. including a peer health mediator, participated in the production of supports (practical guide and action sheets) and the animation of the training dedicated to professionals who deploy the system.
The experimental phase. initiated in 2025, combines a randomized controlled study, involving 22 psychiatric poles, and a qualitative implementation study via semi-structured interviews with users and caregivers in psychiatry. The first results, expected in 2026, tabapsy: study experiences tobacco reduction will make it possible to learn lessons for a larger scale.
Tabapsy was presented during the 9es Meetings for research in psychiatry care (RRSPSY), via a poster and oral communication.
• Contact: Isabelle Maillard, sociologist, research engineer, [email protected]
1– Public health France. Mortality of people with mental disorders. Analysis in multiple causes of death certificates in France, 2000-2013.
2– Manderbacka K, Arffman M, Sund R, Haukka J, et al. How does a history of psychiatric hospital care influence access to coronary care: a cohort study. BMJ Open. 2012;2:e000831.
3– de Hert M, Vancampfort D, Correll CU, Mercken V, et al. Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. Br J Psychiatry. août 2011;199(2):99‑105.
4– Bouvet C, smoking and psychiatry. Inf psychiatr. 2007; 83 (1): 41-7.
5– Ketterer, F., Roelandt, J. and Chevreul, K. (2022). Smoking in psychiatry: realities and implications for its management. Public health, vol. 34 (5), 643-651. tabapsy: study experiences tobacco reduction https://doi.org/10.3917/spub.225.0643.
Tabapsy: study experiences tobacco reduction
Further reading: Are you sleeping? You may no longer need to wear the night mask anymore! – Immersing in the slimming obsession of American teens – Why this advice to young mothers does not work according to a study – Fruit juice: consumption continues its “vertiginous” fall in France – A great advance in the treatment of Alzheimer’s?.
